Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAP2K1

RBC: MEK1 · Substrate: ERK(K52R) ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Trametinib98.70.72
Bosutinib89.80.55
Pirtobrutinib81.80.66
Cabozantinib81.20.75
Binimetinib79.10.69
Vemurafenib77.80.60
Neratinib74.70.60
Cobimetinib73.50.64
Sunitinib68.70.52
Tivozanib62.90.67
Gilteritinib58.60.51
Selumetinib54.40.64
Zanubrutinib54.10.79
Nintedanib46.30.61
Capivasertib45.60.64

Known variants

Open in new tab